As our use of online tools expands wildly with the advent of artificial intelligence, so does the demand for data.

In 2025, LitePoint, a global leader in wireless testing solutions, hosted its "Smart Connectivity Unbounded · Testing Drives ...

A technology researcher says a wave of breakthroughs is accelerating faster than public awareness-and faster than U.S. infrastructure can handle.

Data highlights progress in Rakovina’s AI-derived PARP-1 inhibitor programVANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V ...

The new international accounting standard is aimed at more consistent reporting that’s better aligned with how businesses are ...

Surprise said it would violate Arizona law to give a resident license plate recognition records. Other cities have fulfilled ...

A researcher calls for more interoperability, infrastructure expansion, and careful handling of patient data for the use of AI in healthcare.

Eisai Presents New Data On The Continued And Expanding Benefit Of LEQEMBI(R) (Lecanemab-Irmb) Maintenance Treatment In Early Alzheimer's Disease At CTAD 2025. Eisai Presents New Data on the Continued ...

His handpicked ‘experts’ just voted to roll back hepatitis B vaccine guidelines—and reverse a historic public health victory.

Mixed chimerism or relapses following TSC-101 infusions were found to be significantly associated with greater ex vivo expansion of TCR-T cells during the manufacturing process. A new commercial-ready ...

Data demonstrate superior efficacy compared to ruxolitinib, an approved type I JAK2 inhibitor, including reductions in mutant ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced that new data on Signatera ...